- Home
- ENLV vs GRFX Comparison
ENLV vs GRFX Comparison
Compare ENLV & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- GRFX
- Stock Information
- Founded
- ENLV 2005
- GRFX 1981
- Country
- ENLV Israel
- GRFX Hong Kong
- Employees
- ENLV N/A
- GRFX N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- GRFX
- Sector
- ENLV Health Care
- GRFX
- Exchange
- ENLV Nasdaq
- GRFX Nasdaq
- Market Cap
- ENLV 20.7M
- GRFX 18.1M
- IPO Year
- ENLV 1995
- GRFX N/A
- Fundamental
- Price
- ENLV $0.92
- GRFX $0.99
- Analyst Decision
- ENLV Strong Buy
- GRFX Hold
- Analyst Count
- ENLV 2
- GRFX 1
- Target Price
- ENLV $10.00
- GRFX N/A
- AVG Volume (30 Days)
- ENLV 62.6K
- GRFX 40.4K
- Earning Date
- ENLV 06-13-2025
- GRFX 01-01-0001
- Dividend Yield
- ENLV N/A
- GRFX N/A
- EPS Growth
- ENLV N/A
- GRFX N/A
- EPS
- ENLV N/A
- GRFX N/A
- Revenue
- ENLV N/A
- GRFX $24,184,100.00
- Revenue This Year
- ENLV N/A
- GRFX N/A
- Revenue Next Year
- ENLV N/A
- GRFX N/A
- P/E Ratio
- ENLV N/A
- GRFX N/A
- Revenue Growth
- ENLV N/A
- GRFX N/A
- 52 Week Low
- ENLV $0.81
- GRFX $0.71
- 52 Week High
- ENLV $1.84
- GRFX $2.75
- Technical
- Relative Strength Index (RSI)
- ENLV 44.97
- GRFX 46.25
- Support Level
- ENLV $0.86
- GRFX $0.85
- Resistance Level
- ENLV $0.91
- GRFX $1.00
- Average True Range (ATR)
- ENLV 0.06
- GRFX 0.15
- MACD
- ENLV 0.00
- GRFX -0.01
- Stochastic Oscillator
- ENLV 47.06
- GRFX 34.03
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About GRFX Graphex Group Limited each representing 20
Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.